Close
Digital Health & Ai Innovation summit 2026
APE 2026

Greiner Bio-One: Extension of the intended purpose: Virus safely under lock and key

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Konica Minolta and deepc AI Partnership...

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed...

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Since the alarming news about the global Covid-19 pandemic and its far-reaching effects, the detection of viruses has increasingly moved into the focus of the health care system. With the VACUETTE® Virus Stabilization Tube, Greiner Bio-One can make a significant contribution to virus detection.

Kremsmünster, February 2021 – The VACUETTE® Virus Stabilization Tube supports the safe transport and storage of samples. VACUETTE® transport line products provide additional security when delivering nasopharyngeal and oropharyngeal swabs in the virus stabilization tube to the laboratory.

At the beginning of the year, the purpose of the tube was expanded. Previously it was only intended for the transport and storage of samples that were to be used for the detection of Sars-CoV-2, but the detection of Influenza A and Influenza B is now also included.

 

Latest stories

Related stories

Konica Minolta and deepc AI Partnership Expands Exa Platform

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »